| MolName | (2Z)-2-[(5E)-5-[[5-(4-bromophenyl)furan-2-yl]methylidene]-4-oxo-3-phenyl-1,3-thiazolidin-2-ylidene]-N-(3-chlorophenyl)-2-cyanoacetamide |
| MolecularFormula | C29H17N3O3BrClS |
| Smiles | N#C/C(/C(Nc1cc(Cl)ccc1)=O)=C(\N(C1=O)c2ccccc2)/S/C1=C/c1ccc(-c(cc2)ccc2Br)o1 |
| InChI | InChI=1S/C29H17BrClN3O3S/c30-19-11-9-18(10-12-19)25-14-13-23(37-25)16-26-28(36)34(22-7-2-1-3-8-22)29(38-26)24(17-32)27(35)33-21-6-4-5-20(31)15-21/h1-16H,(H,33,35) |
| InChIK | QNNSAICOBXRVCC-UHFFFAOYSA-N |
| TotalMolweight | 602.895 |
| Molweight | 602.895 |
| MonoisotopicMass | 600.98625 |
| CLogP | 6.9846 |
| CLogS | -9.343 |
| H Acceptors | 6 |
| H Donors | 1 |
| TotalSurfaceArea | 406.87 |
| Relative PSA | 0.21198 |
| PolarSurfaceArea | 111.64 |
| Druglikeness | -0.3144 |
| Mutagenic | high |
| Tumorigenic | high |
| Reproductive Effective | high |
| Irritant | high |
| Nasty Functions | polar activated DB; twice activated DB |
| Shape Index | 0.5 |
| Fragments | 1 |
| Non HAtoms | 38 |
| NonCHAtoms | 9 |
| Electronegative Atoms | 9 |
| Rotatable Bond | 5 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 23 |
| Sp3Atoms | 1 |
| Symmetricatoms | 4 |
| Amides | 2 |
| StereoCon |
Click to Load Molecule:
1 - (2Z)-2-[(5E)-5-[[5-(4-bromophenyl)furan-2-yl]methylidene]-4-oxo-3-phenyl-1,3-thiazolidin-2-ylidene]-N-(3-chlorophenyl)-2-cyanoacetamide | 2 - (2Z)-2-[(5E)-5-[[5-(4-bromophenyl)furan-2-yl]methylidene]-4-oxo-3-phenyl-1,3-thiazolidin-2-ylidene]-N-(3-chlorophenyl)-2-cyanoacetamide